Furthermore, both intratumoral and plasma osteopontin have been linked to tumor hypoxia, and secretion of osteopontin is increased in senescence-associated T cells, therefore considered as immunosenescence marker [44, 45, 47, 51, 57]. Here, SPP1 is linked to neoplasm.